These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27846092)

  • 21. Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions.
    Meex RC; Phielix E; Moonen-Kornips E; Schrauwen P; Hesselink MK
    J Clin Endocrinol Metab; 2011 May; 96(5):1415-23. PubMed ID: 21289240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans.
    Hussain MA; Schmitz O; Mengel A; Keller A; Christiansen JS; Zapf J; Froesch ER
    J Clin Invest; 1993 Nov; 92(5):2249-56. PubMed ID: 8227340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the insulin resistance of puberty and the insulin-like growth factor-I/growth hormone axis.
    Moran A; Jacobs DR; Steinberger J; Cohen P; Hong CP; Prineas R; Sinaiko AR
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4817-20. PubMed ID: 12364479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct effects of locally administered lipopolysaccharide on glucose, lipid, and protein metabolism in the placebo-controlled, bilaterally infused human leg.
    Buhl M; Bosnjak E; Vendelbo MH; Gjedsted J; Nielsen RR; K-Hafstrøm T; Vestergaard ET; Jessen N; Tønnesen E; Møller AB; Pedersen SB; Pilegaard H; Biensø RS; Jørgensen JO; Møller N
    J Clin Endocrinol Metab; 2013 May; 98(5):2090-9. PubMed ID: 23543661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation.
    Strączkowski M; Karczewska-Kupczewska M; Adamska A; Otziomek E; Kowalska I; Nikołajuk A
    Int J Obes (Lond); 2013 Oct; 37(10):1386-90. PubMed ID: 23419601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans.
    Soop M; Duxbury H; Agwunobi AO; Gibson JM; Hopkins SJ; Childs C; Cooper RG; Maycock P; Little RA; Carlson GL
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1276-85. PubMed ID: 12006357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
    Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
    J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incretin effect in critically ill patients: a case-control study.
    Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
    Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children.
    Cogo PE; Carnielli VP; Rosso F; Cesarone A; Giordano G; Faggian D; Plebani M; Barreca A; Zacchello F
    Crit Care Med; 2002 Jan; 30(1):65-70. PubMed ID: 11902289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between euglycemic hyperinsulinemic clamp and surrogate indices of insulin sensitivity in children with growth hormone deficiency.
    Ciresi A; Guarnotta V; Pizzolanti G; Giordano C
    Growth Horm IGF Res; 2018 Apr; 39():40-44. PubMed ID: 29274847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants.
    Beardsall K; Ogilvy-Stuart AL; Frystyk J; Chen JW; Thompson M; Ahluwalia J; Ong KK; Dunger DB
    J Pediatr; 2007 Dec; 151(6):611-7, 617.e1. PubMed ID: 18035140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acarbose actions on insulin resistance and inflammatory parameters during an oral fat load.
    Derosa G; Maffioli P; Ferrari I; Fogari E; D'Angelo A; Palumbo I; Randazzo S; Bianchi L; Cicero AF
    Eur J Pharmacol; 2011 Jan; 651(1-3):240-50. PubMed ID: 21118681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation.
    Agus MS; Javid PJ; Ryan DP; Jaksic T
    J Pediatr Surg; 2004 Jun; 39(6):839-44; discussion 839-44. PubMed ID: 15185208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity.
    Kotronen A; Lewitt M; Hall K; Brismar K; Yki-Järvinen H
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4867-72. PubMed ID: 18796514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in free rather than total insulin-like growth factor-I enhance insulin sensitivity and suppress endogenous peak growth hormone (GH) release following short-term low-dose GH administration in young healthy adults.
    Yuen K; Frystyk J; Umpleby M; Fryklund L; Dunger D
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3956-64. PubMed ID: 15292333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of gender on lipid-induced insulin resistance in obese subjects.
    Vistisen B; Hellgren LI; Vadset T; Scheede-Bergdahl C; Helge JW; Dela F; Stallknecht B
    Eur J Endocrinol; 2008 Jan; 158(1):61-8. PubMed ID: 18166818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.